M6A methylation modification in autoimmune diseases, a promising treatment strategy based on epigenetics

M6A methylation modification in autoimmune diseases, a promising treatment strategy based on epigenetics

Abstract Background N6-methyladenosine (m6A) methylation modification is involved in the regulation of various biological processes, including inflammation, antitumor, and antiviral immunity. However, the role of m6A modification in the pathogenesis of autoimmune diseases has been rarely reported. M...

Full description

Bibliographic Details
Main Authors: Yurong Huang, Qiuyun Xue, Jun Chang, Yuting Wang, Chenglong Cheng, Suowen Xu, Xiao Wang, Chenggui Miao
Format: Article
Language:English
Published: BMC 2023-10-01
Series:Arthritis Research & Therapy
Subjects:
m6a methylation modification
Methylation regulation
Autoimmune diseases
Rheumatoid arthritis
Systemic lupus erythematosus
Online Access:https://doi.org/10.1186/s13075-023-03149-w

Internet

https://doi.org/10.1186/s13075-023-03149-w

Similar Items